CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Three Blockchain Network Agreements Across Three Industries
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that MindWave signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure for clients in climate finance, sports media and insurance. The agreements include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the agreements, MindWave will receive contracted fees or equity along with allocations…





